DEVAX

Devax, a private emerging medical device company located in Irvine, California, is engaged in the development of a proprietary, drug-eluting bifurcated stent system, the AXXESS PLUS, that provides a clinical solution to treat atherosclerotic disease in coronary bifurcation lesions. Devax is currently conducting a pivotal clinical trial in support of FDA approval.